» Articles » PMID: 6705451

Kinetics of the Epimeric Glucocorticoid Budesonide

Overview
Publisher Wiley
Specialty Pharmacology
Date 1984 Apr 1
PMID 6705451
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Budesonide is a potent nonhalogenated glucocorticoid consisting of a 1/1 mixture of the two epimers 22R and 22S. The kinetics of these epimers were studied in six healthy male subjects after intravenous administration of 500 micrograms 3H-budesonide. Estimation of the epimer concentrations in plasma was made possible by development of an HPLC method for simultaneous separation and quantification. The plasma t 1/2, distribution volume (V beta), and plasma clearance for epimer 22R were (mean +/- SD) 2.66 +/- 0.57 hr, 425 +/- 100 l, and 117 +/- 40 l/hr. The corresponding values for epimer 22S were 2.71 +/- 0.69 hr, 245 +/- 38 l, and 67 +/- 19 l/hr. Differences in V beta and plasma clearance between the two were significant. The larger V beta noted for epimer 22R may be a result of higher tissue affinity. The high plasma clearance for both epimers should largely reflect their high rate of liver biotransformation.

Citing Articles

The Design of Novel 3D-Printed, Moulded, and Oral Viscous Budesonide Formulations for Paediatrics: A Comparative Evaluation of Their Mucoadhesive Properties.

Magarinos-Trivino M, Diaz-Torres E, Suarez-Gonzalez J, Santovena-Estevez A, Farina J Pharmaceutics. 2024; 16(10).

PMID: 39458665 PMC: 11510639. DOI: 10.3390/pharmaceutics16101338.


Clinical Pharmacology in Adult and Pediatric Inflammatory Bowel Disease.

Hemperly A, Sandborn W, Vande Casteele N Inflamm Bowel Dis. 2018; 24(12):2527-2542.

PMID: 29788338 PMC: 11187819. DOI: 10.1093/ibd/izy189.


Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Inflammatory Bowel Disease.

Derijks L, Wong D, Hommes D, van Bodegraven A Clin Pharmacokinet. 2018; 57(9):1075-1106.

PMID: 29512050 DOI: 10.1007/s40262-018-0639-4.


Budesonide for the treatment of ulcerative colitis.

Abdalla M, Herfarth H Expert Opin Pharmacother. 2016; 17(11):1549-59.

PMID: 27157244 PMC: 4989907. DOI: 10.1080/14656566.2016.1183648.


Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.

Quetglas E, Armuzzi A, Wigge S, Fiorino G, Barnscheid L, Froelich M Eur J Clin Pharmacol. 2015; 71(7):773-99.

PMID: 26008212 DOI: 10.1007/s00228-015-1862-7.